Hybrid coronary revascularization: Time for a new comparator?

Naoki Misumida, David J. Moliterno

Research output: Contribution to journalEditorial

1 Scopus citations

Abstract

The present meta-analysis found no significant difference between hybrid coronary revascularization (HCR) and bypass surgery (CABG) regarding intermediate-term major adverse cardiac and cerebrovascular events. HCR is feasible, historically with higher revascularization rates but less perioperative morbidity With a comparable frequency of repeat revascularization between current-generation drug-eluting stents and CABG, future trials of HCR are considering multi-vessel PCI as the new comparator.

Original languageEnglish
Pages (from-to)213-214
Number of pages2
JournalCatheterization and Cardiovascular Interventions
Volume91
Issue number2
DOIs
StatePublished - Feb 1 2018

Bibliographical note

Publisher Copyright:
© 2018 Wiley Periodicals, Inc.

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Hybrid coronary revascularization: Time for a new comparator?'. Together they form a unique fingerprint.

Cite this